MS Drug

[anonymous]

The one and only. A#1 POS

Can you give some details. I'm considering an,opportunity but WHO you Work for directly is more important than the company, thank you for honest responses.

 

[anonymous]

Any intel on the Regional in the west? Bill somebody from Biogen?

 

[anonymous]

looks like either poor sales reps or Biogen TLL's or internal, sad way to start a division in MS.

So true on Lots of people being from Biogen.

 

[anonymous]

considering the senior leadership in place for MS, don't be surprised that the turns into the landing area for many Biogen reps and managers

Yeap! While Genzyme was a landing pad for many Serono folks, Genentech will be the landing pad for Biogen folks. Hopefully they hire reps who launched Tysabri. Otherwise those Biogen reps will be useless

 

[anonymous]

looks like either poor sales reps or Biogen TLL's or internal, sad way to start a division in MS.

 

[anonymous]

Biogen pukes in leadership roles, Genentech has sold out their own people. North East region manager the worst of the worst from Biogen

KC is on her way. She's great.

 

[anonymous]

Biogen pukes in leadership roles, Genentech has sold out their own people. North East region manager the worst of the worst from Biogen

Anyone who would make this comment has not worked for SH. Biogen is and was filled with jerkoffs in senior management and he was absolutely not one of them. The dude is solid leader and in favor of his people. He may like to slug a drunk or 2 and may dig chicks but none of that shit matters. As this shit business evolves what matters is who you work for. I defy the dicksmoker who posted this about him to name one senior manager better than him. I'd guarantee you that anyone that worked in the northeast would tell you he's one of the best they've ever worked for.

 

[anonymous]

I can't wait for this drug to launch

 

[anonymous]

I can't wait for this drug to launch

Delayed

 

[anonymous]

Delayed

What?

 

[anonymous]

What?

Have to complete another safety study- not looking good till end of 2017 beginning of 2018. But when we do launch it will be best in class.

 

[anonymous]

Have to complete another safety study- not looking good till end of 2017 beginning of 2018. But when we do launch it will be best in class.

You're so full of shit. They wouldn't have hired managers to sit around for that long.

 

[anonymous]

Have to complete another safety study- not looking good till end of 2017 beginning of 2018. But when we do launch it will be best in class.

Proof?

 

[anonymous]

KC is on her way. She's great.

LMFAO- OMG- my stomach hurts I am laughing so hard.
Thanks Katie for your insightful comments- self promoting as always.
Please someone stop her now I cannot keep laughing like this

 

[anonymous]

Delayed

 

[anonymous]

Delayed

.
Wrong so absolutely WRONG!

 

[anonymous]

.
Wrong so absolutely WRONG!

I'm, not really. I heard possibly until very late this year or early next year. Sorry to burst your bubble

 

[anonymous]

I'm, not really. I heard possibly until very late this year or early next year. Sorry to burst your bubble

Yes you are wrong. Not sure where you got your info. The original approval was always expected late 2016 early 2017. No new safety study needed.

http://www.businesswire.com/news/ho...erapy-Designation-Genentech’s-Investigational

 

[anonymous]

I'm, not really. I heard possibly until very late this year or early next year. Sorry to burst your bubble

I love coming on this board to see how many r*****s are on this planet- makes me feel even smarter than I already am. This OP is a toolbag. Drug just got breakthrough status

 

[anonymous]

I love coming on this board to see how many r*****s are on this planet- makes me feel even smarter than I already am. This OP is a toolbag. Drug just got breakthrough status

Let's try another adjective other than what you used. Then again, it may be asking too much of you if you so easily through that term around. Hopefully you won't be selling Ocre......